MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 116 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q4 2020. The put-call ratio across all filers is 0.09 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $2,730,000 | -34.0% | 77,389 | -21.6% | 0.80% | -12.4% |
Q4 2021 | $4,135,000 | -6.4% | 98,688 | +9.7% | 0.91% | -18.4% |
Q3 2021 | $4,417,000 | +17.6% | 90,000 | 0.0% | 1.12% | +36.1% |
Q2 2021 | $3,756,000 | -6.3% | 90,000 | -20.0% | 0.82% | -11.8% |
Q1 2021 | $4,010,000 | +29.6% | 112,500 | +2.0% | 0.93% | +17.6% |
Q4 2020 | $3,093,000 | – | 110,276 | – | 0.79% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |